Tumor endothelial cells

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 3, 2012, Pages

  Dudley, Andrew C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE ANTIGEN; MICRORNA; TUMOR MARKER; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VINCRISTINE; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD FLOW; BLOOD VESSEL PARAMETERS; CONGENITAL BLOOD VESSEL MALFORMATION; DEFECTIVE ENDOTHELIAL MONOLAYER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HYPOXIA; IMMUNOMAGNETIC SEPARATION; INTUSSUSCEPTIVE ANGIOGENESIS; LASER CAPTURE MICRODISSECTION; METASTASIS; NONHUMAN; PHENOTYPE; SCANNING ELECTRON MICROSCOPY; SERIAL ANALYSIS OF GENE EXPRESSION; SMOOTH MUSCLE FIBER; TUMOR CELL; TUMOR GROWTH; VASCULAR ENDOTHELIUM; VASCULAR TUMOR; ANIMAL; BLOOD VESSEL; CYTOLOGY; DISEASE COURSE; DRUG ANTAGONISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT; VASCULARIZATION; VENULE;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; DISEASE PROGRESSION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MYOCYTES, SMOOTH MUSCLE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENULES;

EID: 84877679070     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006536     Document Type: Article

References (156)

1. Aghi M, Chiocca EA. 2005. Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Mol Ther 12: 994-1005.
2. Ahn G-O, Brown JM. 2008. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells. Cancer Cell 13: 193-205.
3. Ahn G-O, Tseng D, Liao C-H, Dorie MJ, Czechowicz A, Brown JM. 2010. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci 107: 8363-8368.
4. Aird WC. 2006. Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res 98: 159-162.
5. Aird WC. 2009. Molecular heterogeneity of tumor endothelium. Cell Tissue Res 335: 271-281.
6. Alessandri G, Chirivi RG, Fiorentini S, Dossi R, Bonardelli S, Giulini SM, ZanettaG, Landoni F, Graziotti PP, Turano A, et al. 1999. Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells. Clin Exp Metastasis 17: 655-662.
7. Allport JR, Weissleder R. 2003. Murine Lewis lung carcinoma-derived endothelium expresses markers of endothelial activation and requires tumor-specific extracellular matrix in vitro. Neoplasia 5: 205-217.
8. Amin DN, Hida K, Bielenberg DR, Klagsbrun M. 2006. Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res 66: 2173-2180.
9. Amin DN, Bielenberg DR, Lifshits E, Heymach JV, Klagsbrun M. 2008. Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells. Microvasc Res 76: 15-22.
10. Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, et al. 2010. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 16: 909-914.
11. Arbiser JL, Raab G, Rohan RM, Paul S, Hirschi K, Flynn E, Price ER, Fisher DE, Cohen C, Klagsbrun M. 1999. Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. Am J Pathol 155: 723-729.
12. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, WitzenbichlerB, Schatteman G, Isner JM. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
13. Ausprunk DH, Knighton DR, Folkman J. 1975. Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. Am J Pathol 79: 597-618.
14. Bailey AS, Willenbring H, Jiang S, Anderson DA, Schroeder DA, Wong MH, Grompe M, Fleming WH. 2006. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci 103: 13156-13161.
15. Baker CH, Kedar D, McCarty MF, Tsan R, Weber KL, Bucana CD, Fidler IJ. 2002. Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol 161: 929-938.
16. Baluk P, Hashizume H, McDonald DM. 2005. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15: 102-111.
17. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL. 2002. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 16: 2530-2543.
18. Bergers G, Hanahan D. 2008. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8: 592-603.
19. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. 1999. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808-812.
20. Bhati R, Patterson C, Livasy CA, Fan C, Ketelsen D, Hu Z, Reynolds E, Tanner C, Moore DT, Gabrielli F, et al. 2008. Molecular characterization of human breast tumor vascular cells. Am J Pathol 172: 1381-1390.
21. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, et al. 1999. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154: 385-394.
22. Buckanovich RJ, Sasaroli D, O'Brien-Jenkins A, Botbyl J, Hammond R, KatsarosD, Sandaltzopoulos R, Liotta LA, Gimotty PA, Coukos G. 2007. Tumor vascular proteins as biomarkers in ovarian cancer. J Clin Oncol 25: 852-861.
23. Burri PH, Hlushchuk R, Djonov V. 2004. Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance. Dev Dyn 231: 474-488.
24. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G. 2003. Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J 17: 1159-1161.
25. Bussolati B, Grange C, Bruno S, Buttiglieri S, Deregibus MC, Tei L, Aime S, Camussi G. 2006. Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures. Exp Cell Res 312: 913-924.
26. Butler JM, Kobayashi H, Rafii S. 2010. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 10: 138-146.
27. + cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35: 1109-1118.
28. Cassoni P, Marrocco T, Bussolati B, Allia E, Munaron L, Sapino A, Bussolati G. 2006. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells. Mol Cancer Res 4: 351-359.
29. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL. 2000. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci 97: 14608-14613.
30. Chappell JC, Taylor SM, Ferrara N, Bautch VL. 2009. Local guidance of emerging vessel sprouts requires soluble Flt-1. Dev Cell 17: 377-386.
31. Charalambous C, Pen LB, Su YS, Milan J, Chen TC, Hofman FM. 2005. Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res 65: 10347-10354.
32. Chi J-T, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, et al. 2003. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci 100: 10623-10628.
33. Coffelt SB, Lewis CE, Naldini L, Brown JM, Ferrara N, De Palma M. 2010. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol 176: 1564-1576.
34. Coussens LM, Tinkle CL, Hanahan D, Werb Z. 2000. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490.
35. Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z, Kaminker J, FerraraN. 2009. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15: 21-34.
36. Cullen M, Seaman S, Chaudhary A, Yang MY, Hilton MB, Logsdon D, HainesDC, Tessarollo L, St Croix B. 2009. Host-derived tumor endothelial marker 8 promotes the growth of melanoma. Cancer Res 69: 6021-6026.
37. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, NaldiniL. 2005. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226.
38. De Val S, Black BL. 2009. Transcriptional control of endothelial cell development. Dev Cell 16: 180-195.
39. Dickson PV, Hamner JB, Sims TL, Fraga CH, Ng CYC, Rajasekeran S, HagedornNL, McCarville MB, Stewart CF, Davidoff AM. 2007. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy. Clin Cancer Res 13: 3942-3950.
40. Dirkx AEM, oude Egbrink MGA, Castermans K, van der Schaft DWJ, ThijssenVLJL, Dings RPM, Kwee L, Mayo KH, Wagstaff J, Bouma-ter Steege JCA, et al. 2006. Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors. FASEB J20: 621-630.
41. di Tomaso E, Capen D, Haskell A, Hart J, Logie JJ, Jain RK, McDonald DM, JonesR, Munn LL. 2005. Mosaic tumor vessels: Cellular basis and ultrastructure of focal regions lacking endothelial cell markers. Cancer Res 65: 5740-5749.
42. Doublier S, Ceretto M, Lupia E, Bravo S, Bussolati B, Camussi G. 2007. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase. Clin Cancer Res 13: 5710-5718.
43. Dudley AC, Khan ZA, Shih S-C, Kang S-Y, Zwaans BMM, Bischoff J, KlagsbrunM. 2008a. Calcification of multipotent prostate tumor endothelium. Cancer Cell 14: 201-211.
44. Dudley AC, Shih S-C, Cliffe AR, Hida K, Klagsbrun M. 2008b. Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine. Br J Cancer 99: 118-125.
45. Dudley AC, Udagawa T, Melero-Martin JM, Shih S-C, Curatolo A, Moses MA, Klagsbrun M. 2010. Bone marrow is a reservoir for pro-angiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors. Blood 116: 3367-3371.
46. Dvorak HF. 1986. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659.
47. Ebos JML, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS. 2009. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15: 232-239.
48. Ehnfors J, Kost-Alimova M, Persson NL, Bergsmedh A, Castro J, Levchenko-Tegnebratt T, Yang L, Panaretakis T, Holmgren L. 2009. Horizontal transfer of tumor DNA to endothelial cells in vivo. Cell Death Differ 16: 749-757.
49. Ellis LM, Hicklin DJ. 2008. Pathways mediating resistance to vascular endothelial growth factor-targeted therapy. Clin Cancer Res 14: 6371-6375.
50. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, Peri F, WilsonSW, Ruhrberg C. 2010. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116: 829-840.
51. Fonsato V, Buttiglieri S, Deregibus MC, Puntorieri V, Bussolati B, Camussi G. 2006. Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis. Am J Pathol 168: 706-713.
52. Garbi N, Arnold B, Gordon S, Hämmerling GJ, Ganss R. 2004. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction. J Immunol 172: 5861-5869.
53. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, et al. 2003. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177.
54. Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber DE. 2008. Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci 105: 11305-11310.
55. Gimbrone MA, Cotran RS, Folkman J. 1974. Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol 60: 673-684.
56. Grange C, Bussolati B, Bruno S, Fonsato V, Sapino A, Camussi G. 2006. Isolation and characterization of human breast tumor-derived endothelial cells. Oncol Rep 15: 381-386.
57. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G. 1996. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: The role of angiogenic factors. Cancer Res 56: 1111-1117.
58. Grover AC, Tangrea MA, Woodson KG, Wallis BS, Hanson JC, Chuaqui RF, Gillespie JW, Erickson HS, Bonner RF, Pohida TJ, et al. 2006. Tumor-associated endothelial cells display GSTP1 and RARβ2 promoter methylation in human prostate cancer. J Trans Med 4: 13.
59. Haddad O, Chotard-Ghodsnia R, Verdier C, Duperray A. 2009. Tumor cell/endothelial cell tight contact upregulates endothelial adhesion molecule expression mediated by NFκB: Differential role of the shear stress. Exp Cell Res 316: 615-626.
60. Halder C, Ossendorf C, Maran A, Yaszemski M, Bolander ME, Fuchs B, Sarkar G. 2009. Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma. Anticancer Res 29: 4317-4322.
61. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S Jain RK, McDonald DM. 2000. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156: 1363-1380.
62. Hayasaka H, Taniguchi K, Fukai S, Miyasaka M. 2010. Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking. Cancer Sci 101: 2302-2308.
63. Helfrich I, Scheffrahn I, Bartling S, Weis J, Von Felbert V, Middleton M, Kato M, Ergun S, Schadendorf D. 2010. Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. J Exp Med 207: 491-503.
64. Hellebrekers DMEI, Melotte V, Viré E, Langenkamp E, Molema G, Fuks F, Herman JG, Van Criekinge W, Griffioen AW, van Engeland M. 2007. Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res 67: 4138-4148.
65. Hellström M, Gerhardt H, Kalén M, Li X, Eriksson U, Wolburg H, Betsholtz C. 2001. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543-553.
66. Hellström M, Phng L-K, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, Alva J, Nilsson A-K, Karlsson L, Gaiano N, et al. 2007. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445: 776-780.
67. Hendrix MJC, Seftor EA, Hess AR, Seftor REB. 2003. Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nat Rev Cancer 3: 411-421.
68. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M. 2004. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64: 8249-8255.
69. Hill R, Song Y, Cardiff RD, Van Dyke T. 2005. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123: 1001-1011.
70. Hirschi KK, D'Amore PA. 1996. Pericytes in the microvasculature. Cardiovasc Res 32: 687-698.
71. Hobson B, Denekamp J. 1984. Endothelial proliferation in tumours and normal tissues: Continuous labelling studies. Br J Cancer 49: 405-413.
72. Hoffman JA, Giraudo E, Singh M, Zhang L, Inoue M, Porkka K, Hanahan D, Ruoslahti E. 2003. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell 4: 383-391.
73. Hynes RO. 2009. The extracellular matrix: Not just pretty fibrils. Science 326: 1216-1219.
74. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC. 2005. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105: 2783-2786.
75. Issa Y, Nummer D, Seibel T, Müerköster SS, Koch M, Schmitz-Winnenthal F-H, Galindo L, Weitz J, Beckhove P, Altevogt P. 2009. Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration. J Mol Med 87: 99-112.
76. Jain RK. 2005. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307: 58-62.
77. Jayasinghe C, Simiantonaki N, Michel-Schmidt R, Kirkpatrick CJ. 2009. Comparative study of human colonic tumor-derived endothelial cells (HCTEC) and normal colonic microvascular endothelial cells (HCMEC): Hypoxia-induced sVEGFR-1 and sVEGFR-2 levels. Oncol Rep 21: 933-939.
78. Jin S-W, Patterson C. 2009. The opening act: Vasculogenesis and the origins of circulation. Arterioscler Thromb Vasc Biol 29: 623-629.
79. Johnson CS, Chung I, Trump DL. 2010. Epigenetic silencing of CYP24 in the tumor microenvironment. J Steroid Biochem Mol Biol 121: 338-342.
80. Joyce JA, Laakkonen P, Bernasconi M, Bergers G, Ruoslahti E, Hanahan D. 2003. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 4: 393-403.
81. Jurisic G, Iolyeva M, Proulx ST, Halin C, Detmar M. 2010. Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium. Exp Cell Res 316: 2982-2992.
82. Kalluri R. 2003. Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433.
83. Kamoun WS, Chae S-S, Lacorre DA, Tyrrell JA, Mitre M, Gillissen MA, FukumuraD, Jain RK, Munn LL. 2010. Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks. Nat Methods 7: 655-660.
84. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et al. 2005. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
85. Kerbel RS, Benezra R, Lyden DC, Hattori K, Heissig B, Nolan DJ, Mittal V, Shaked Y, Dias S, Bertolin F, et al. 2008. Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas. Proc Natl Acad Sci 105: E54 (author reply E55).
86. Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, MullikenJB, Bischoff J. 2008. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 118: 2592-2599.
87. Kim S-J, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ. 2003. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice. Clin Cancer Res 9: 1200-1210.
88. Klagsbrun M, Eichmann A. 2005. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 16: 535-548.
89. Konerding MA, Malkusch W, Klapthor B, van Ackern C, Fait E, Hill SA, ParkinsC, Chaplin DJ, Presta M, Denekamp J. 1999. Evidence for characteristic vascular patterns in solid tumours: Quantitative studies using corrosion casts. Br J Cancer 80: 724-732.
90. Lacaud G, Keller G, Kouskoff V. 2004. Tracking mesoderm formation and specification to the hemangioblast in vitro. Trends Cardiovasc Med 14: 314-317.
91. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, Lacaud G. 2009. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 457: 892-895.
92. Lee HK, Bae HR, Park HK, Seo IA, Lee EY, Suh DJ, Park HT. 2005. Cloning, characterization and neuronal expression profiles of tumor endothelial marker 7 in the rat brain. Brain Res Mol Brain Res 136: 189-198.
93. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SFT, Csiszar K, Giaccia A, Weninger W, et al. 2009. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906.
94. Lin EY, Li J-F, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue X-n, Pollard JW. 2006. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66: 11238-11246.
95. Loeffler M, Krüger JA, Niethammer AG, Reisfeld RA. 2006. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 116: 1955-1962.
96. Lu C, Bonome T, Li Y, Kamat AA, Han LY, Schmandt R, Coleman RL, Gershenson DM, Jaffe RB, Birrer MJ, et al. 2007. Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res 67: 1757-1768.
97. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, et al. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201.
98. MacFadyen J, Savage K, Wienke D, Isacke CM. 2007. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. Gene Expr Patterns 7: 363-369.
99. Madden SL, Cook BP, Nacht M, Weber WD, Callahan MR, Jiang Y, Dufault MR, Zhang X, Zhang W, Walter-Yohrling J, et al. 2004. Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol 165: 601-608.
100. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, MeltzerPS, Hendrix MJ. 1999. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol 155: 739-752.
101. Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation. Nature 454: 436-444.
102. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, TianY-M, Lanahan AA, Pollard P, Ruiz de Almodovar C, et al. 2009. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136: 839-851.
103. McDonald DM, Choyke PL. 2003. Imaging of angiogenesis: From microscope to clinic. Nat Med 9: 713-725.
104. McDonald DM, Munn L, Jain RK. 2000. Vasculogenic mimicry: How convincing, how novel, and how significant? Am J Pathol 156: 383-388.
105. Melero-Martin J, De Obaldia M, Kang S-Y, Khan Z, Yuan L, Oettgen P, BischoffJ. 2008. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103: 194.
106. Merlo LMF, Pepper JW, Reid BJ, Maley CC. 2006. Cancer as an evolutionary and ecological process. Nat Rev Cancer 6: 924-935.
107. Miebach S, Grau S, Hummel V, Rieckmann P, Tonn J-C, Goldbrunner RH. 2006. Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades. J Neurooncol 76: 39-48.
108. Murdoch C, Muthana M, Coffelt SB, Lewis CE. 2008. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8: 618-631.
109. Nagy JA, Dvorak AM, Dvorak HF. 2007. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2: 251-275.
110. Nagy JA, Chang S-H, Dvorak AM, Dvorak HF. 2009. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer 100: 865-869.
111. Nagy JA, Chang S-H, Shih S-C, Dvorak AM, Dvorak HF. 2010. Heterogeneity of the tumor vasculature. Semin Thromb Hemost 36: 321-331.
112. Nozawa H, Chiu C, Hanahan D. 2006. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci 103: 12493-12498.
113. + regulatory T cell infiltration of human pancreatic carcinoma. J Natl Cancer Inst 99: 1188-1199.
114. Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, Testa JE, Schnitzer JE. 2004. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429: 629-635.
115. Opavsky R, Haviernik P, Jurkovicova D, Garin MT, Copeland NG, Gilbert DJ, Jenkins NA, Bies J, Garfield S, Pastorekova S, et al. 2001. Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem 276: 38795-38807.
116. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK. 2004. Pathology: Cancer cells compress intratumour vessels. Nature 427: 695.
117. Parker BS, Argani P, Cook BP, Liangfeng H, Chartrand SD, Zhang M, Saha S, Bardelli A, Jiang Y, St Martin TB, et al. 2004. Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res 64: 7857-7866.
118. Patan S, Munn LL, Jain RK. 1996. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: A novel mechanism of tumor angiogenesis. Microvasc Res 51: 260-272.
119. Patan S, Tanda S, Roberge S, Jones RC, Jain RK, Munn LL. 2001. Vascular morphogenesis and remodeling in a human tumor xenograft: Blood vessel formation and growth after ovariectomy and tumor implantation. Circulation Research 89: 732-739.
120. + cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
121. Pen A, Moreno MJ, Martin J, Stanimirovic DB. 2007. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: Microarray study of laser-captured glioblastoma vessels. Glia 55: 559-572.
122. Polyak K, Haviv I, Campbell IG. 2009. Co-evolution of tumor cells and their microenvironment. Trends Genet 25: 30-38.
123. Purhonen PSS. 2008. Reply to Kerbel, et al. EPCs are again claimed to be essential in yet other models despite the irreproducibility of the original experiments introducing them. Proc Natl Acad Sci 105: E55.
124. Qian B-Z, Pollard JW. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
125. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. 2002. Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2: 826-835.
126. Rehman J, Li J, Orschell CM, March KL. 2003. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
127. Schellerer VS, Croner RS, Weinländer K, Hohenberger W, Stürzl M, Naschberger E. 2007. Endothelial cells of human colorectal cancer and healthy colon reveal phenotypic differences in culture. Lab Invest 87: 1159-1170.
128. Schwartz SM, Benditt EP. 1973. Cell replication in the aortic endothelium: A new method for study of the problem. Lab Invest 28: 699-707.
129. Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B. 2007. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11: 539-554.
130. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, et al. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367.
131. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, LalA, Riggins GJ, Lengauer C, Vogelstein B, et al. 2000. Genes expressed in human tumor endothelium. Science 289: 1197-1202.
132. Streubel B, Chott A, Huber D, Exner M, Jäger U, Wagner O, Schwarzinger I. 2004. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 351: 250-259.
133. Sullivan R, Graham CH. 2007. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26: 319-331.
134. Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y, Satake M, SudaT. 2000. A role for hematopoietic stem cells in promoting angiogenesis. Cell 102: 199-209.
135. Tanaka H, Hori M, Ohki T. 1992. High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast. Virchows Arch A Pathol Anat Histopathol 420: 253-261.
136. Taylor SM, Nevis KR, Park HL, Rogers GC, Rogers SL, Cook JG, Bautch VL. 2010. Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels. Blood 116: 3108-3117.
137. Tilki D, Hohn H-P, Ergün B, Rafii S, Ergün S. 2009. Emerging biology of vascular wall progenitor cells in health and disease. Trends Mol Med 15: 501-509.
138. Tse GM, Tan P-H, Pang ALM, Tang APY, Cheung HS. 2008. Calcification in breast lesions: Pathologists' perspective. J Clin Pathol 61: 145-151.
139. Unger RE, Oltrogge JB, von Briesen H, Engelhardt B, Woelki U, Schlote W, LorenzR, Bratzke H, Kirkpatrick CJ. 2002. Isolation and molecular characterization of brain microvascular endothelial cells from human brain tumors. In Vitro Cell Dev Biol Anim 38: 273-281.
140. van Beijnum JR, Dings RP, van der Linden E, Zwaans BMM, Ramaekers FCS, MayoKH, Griffioen AW. 2006. Gene expression of tumor angiogenesis dissected: Specific targeting of colon cancer angiogenic vasculature. Blood 108: 2339-2348.
141. Verfaillie CM. 2008. Bony endothelium: Tumor-mediated transdifferentiation?Cancer Cell 14: 193-194.
142. Walter-Yohrling J, Morgenbesser S, Rouleau C, Bagley R, Callahan M, Weber W, Teicher BA. 2004. Murine endothelial cell lines as models of tumor endothelial cells. Clin Cancer Res 10: 2179-2189.
143. Wang H-W, Trotter MWB, Lagos D, Bourboulia D, Henderson S, Mäkinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C. 2004. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36: 687-693.
144. Warren BA, Shubik P, Wilson R, Garcia H, Feldman R. 1978. The microcirculation in two transplantable melanomas of the hamster. I. In vivo observations in transparent chambers. Cancer Lett 4: 109-116.
145. Welén K, Jennbacken K, Tesan T, Damber J-E. 2009. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts. Prostate Cancer Prostatic Dis 12: 41-46.
146. Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, VlahovicG, Bendell J, Cohen KS, Hurwitz HI, et al. 2007. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol 4: 316-321.
147. Wu LQ, Zhang WJ, Niu JX, Ye LY, Yang ZH, Grau GE, Lou JN. 2008. Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells. J Vasc Res 45: 78-86.
148. Würdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, WeisslederR, Breakefield XO, Krichevsky AM. 2008. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14: 382-393.
149. Xian X, Håkansson J, Ståhlberg A, Lindblom P, Betsholtz C, Gerhardt H, SembH. 2006. Pericytes limit tumor cell metastasis. J Clin Invest 116: 642-651.
150. Xiong Y-Q, Sun H-C, Zhang W, Zhu X-D, Zhuang P-Y, Zhang J-B, Wang L, WuW-Z, Qin L-X, Tang Z-Y. 2009. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin Cancer Res 15: 4838-4846.
151. Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, MatrisianLM, Carbone DP, Lin PC. 2004. Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6: 409-421.
152. Yoder MC. 2009. Defining human endothelial progenitor cells. J Thromb Haemost 7: 49-52.
153. Yoder MC, Ingram DA. 2009. Endothelial progenitor cell: Ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol 16: 269-273.
154. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. 2007. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809.
155. Yonenaga Y, Mori A, Onodera H, Yasuda S, Oe H, Fujimoto A, Tachibana T, Imamura M. 2005. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 69: 159-166.
156. You L, Wu M, Chen Y, Xu G, Wei J, Li Q, Song A, Zhao L, Li S, Han Z, et al. 2010. Isolation and characterization of lymphatic endothelial cells from human glossal lymphangioma. Oncol Rep 23: 105-111.